815 8th Avenue SW
Suite 600
Calgary, AB T2P 3P2
Canada
855-426-4246
https://universalibogaine.com
Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees:
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Nicholas Peter Karos | CEO, Director of Capital Markets & Director | 240k | N/A | N/A |
Mr. Greg J. Leavens C.A., CPA | CFO & Corporate Secretary | 175k | N/A | 1965 |
Mr. Shayne Nyquvest | Co-Founder | 231.08k | N/A | N/A |
Mr. Dugan Selkirk | Manager Communications & Investor Relations | N/A | N/A | N/A |
Cathy Fernandes | VP of Marketing & VP of Communications | N/A | N/A | N/A |
Universal Ibogaine Inc., a life sciences company, develops, acquires, and operates addiction treatment clinics in Canada. It undertakes planned clinical trial for research into the use of ibogaine for addiction treatment. The company is headquartered in Calgary, Canada.
Universal Ibogaine Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.